Locations:
SearchBernardo Perez-Villa, MD, MSc, Senior Engagement Partner, Innovations, shares with Cardiac Care three promising technologies poised to reshape how we address cardiovascular diseases. Cleveland Clinic Innovations portfolio companies Advanced NanoTherapies Inc., Cardionomic Inc., and Mitria Medical, are featured.
In Cleveland Clinic Florida’s Cardiac Care seasonal newsletter, which includes updates for physicians from the Heart, Vascular and Thoracic Institute, Senior Engagement Partner, Bernardo Perez-Villa highlighted three technologies in development with Cleveland Clinic Innovations that have the potential to transform cardiovascular care.
“It is vital to keep up with cutting-edge developments in the dynamic field of cardiovascular medicine, and many startups armed with pre-market technologies are ready to transform cardiovascular healthcare,” shared Dr. Perez-Villa. “Here, we present three promising technologies that may reshape how we address cardiovascular diseases.”
These three technologies include the SirPluxTM Duo Drug-Coated Balloon, Cardiac Pulmonary Nerve Stimulation (CPNS), and Subvalvular Spacer TM. Created by Advanced NanoTherapies Inc., their proprietary nanotechnology-driven technology, SirPluxDuo Drug-Coated Balloon, utilizes 100% biodegradable nanoparticles for precise drug delivery to the target site. Cardionomic Inc. created the CPNS system. The system holds promise as a potential game-changer in the treatment of acute decompensated heart failure (ADHF). Lastly, Mitria Medical’s Subvalvular Spacer is a percutaneously delivered nitinol braid that is designed to treat mitral regurgitation with a focus on preservation rather than resection.
To learn more about these technologies, read the full article in Cleveland Clinic Florida’s Cardiac Care newsletter.
